Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases

Background: Atopic dermatitis (AD) is a chronic skin disease that affects 5-20% of children. This disease compromises the quality of life. Omalizumab offers a promising role in the treatment of severe atopic dermatitis.Objective: To share our experience with the use of omalizumab for treating severe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Revista Alergia México
Auteurs principaux: María García, Alejandro Durán-Crane, Edgardo Chapman, Elizabeth García
Format: Artigo
Langue:Inglês
Publié: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2019
Sujets:
Medicina
Omalizumab
Clarithromycin
Corticosteroids
Adjuvant therapy
Pediatric atopic dermatitis
Accès en ligne:https://www.redalyc.org/articulo.oa?id=486761439003
https://www.redalyc.org/journal/4867/486761439003/
https://www.redalyc.org/journal/4867/486761439003/html/
https://www.redalyc.org/journal/4867/486761439003/486761439003.epub
https://www.redalyc.org/journal/4867/486761439003/movil
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires